Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

ABSTRACT:

SUBMITTER: Landovitz RJ 

PROVIDER: S-EPMC6224042 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature